Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Mitomycin, Doxorubicin and Cisplatin in the Treatment of Recurrent or Advanced Uterine Sarcomas

NCT00002993 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT00002993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Mitomycin, Doxorubicin and Cisplatin in the Treatment of Recurrent or Advanced Uterine Sarcomas
Lead sponsor
Gynecologic Oncology Group
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 1997
Completion date
Not reported
Enrollment
30 (estimated)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma